Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
No Fizz in Soda Scare
The food police filed a petition this week with the federal government to require that regular (non-diet) soft drinks carry health warning labels. But…
Op-Eds
Short-Term Memory
An unwitting yet hideous example of the politically correct, “can't-we-move-on” short memories of the elites exposed in Tony Blankley's spot-on analysis “Short memories,…
Op-Eds
‘Big Lie’ Enough to Make Drug Industry Ill
Activism can be a good thing. We all benefit from getting to shop in the marketplace of ideas. However, all is not good-faith activism. Take,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES Members of Congress move to restrict some of the most controversial elements…
Newsletter
The Competitive Enterprise Institute Daily Update
1. REGULATION Washington Post columnist Cindy Skrzycki cites CEI’s most recent regulatory study, Ten Thousand Commandments. CEI Expert Available to Comment:…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. GLOBAL WARMING The Bush Administration’s position on global warming is affirmed at the G8…